AG-SITAGLIPTIN
ANGITA PHARMA INC.
Quick answers
Is there a shortage of AG-SITAGLIPTIN in Canada?
No. There is no current shortage of AG-SITAGLIPTIN 25MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
AG-SITAGLIPTIN
ANGITA PHARMA INC.
JAMP SITAGLIPTIN
JAMP PHARMA CORPORATION
AURO-SITAGLIPTIN
AURO PHARMA INC
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
DIN
02535513
Strength
25MG
Dosage Form
Tablet
Route
Oral
Active Ingredient
SITAGLIPTIN (SITAGLIPTIN HYDROCHLORIDE MONOHYDRATE)
See all SITAGLIPTIN (SITAGLIPTIN HYDROCHLORIDE MONOHYDRATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from ANGITA PHARMA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
20MG · DIN 02538350
DIN 02484579
DIN 02484560
70MG · DIN 02506327
5MG · DIN 02369230
10MG · DIN 02369249
2.5MG · DIN 02369222
DIN 02510634
DIN 02510642
500MG · DIN 02477726
250MG · DIN 02537451
1MG · DIN 02534118